13Bioactive and Composite Prosthesis Coatings

FTwo jobs, two materials: the coated-prosthesis idea

An ossicular prosthesis has to do two quite different things at once, and no single material does both perfectly. Mechanically it must be stiff, light and stable— rigid enough to carry sound from drum to stapes without flexing, light enough not to load the chain with mass, and workable enough that the surgeon can trim it to length and seat it precisely. Biologically it must present a friendly face to living tissue — a surface the middle ear tolerates indefinitely, ideally one the eardrum will accept without pushing it back out. The honest difficulty of ossiculoplasty materials is that the best mechanical materials (metals such as titanium) are biologically inert rather than welcoming, while the most biologically welcoming materials (bioactive ceramics such as hydroxyapatite) are mechanically brittle.

The elegant resolution is to stop asking one material to do both jobs. A bioactive-coated or composite prosthesis places a tough, stiff metallic body where the mechanics happen and a thin bioactive layer— classically hydroxyapatite — only at the interface that touches tissue. The archetype is the hydroxyapatite-capped titanium design: a titanium shaft and footplate for rigidity and trimmability, finished with a hydroxyapatite head that the drum or remnant ossicle can bond to. Each material is asked to do only the thing it is best at. The same logic produced the earlier hybrid prostheses with a ceramic head on a flexible polymer or metal shaft, whose low extrusion and improved handling first proved the principle [1992].

FWhy a bioactive surface, not just a biocompatible bulk

It is worth being precise about the word bioactive, because it is the whole point of the coating. Most implant surfaces are bioinert: the body tolerates them but does not embrace them, walling them off in a thin fibrous capsule. The implant sits in the tissue without bonding to it, held in place only by its mechanical seating, free to micromotion and, over months, to migrate. Polished titanium behaves essentially this way. A bioactive surface is different: its chemistry is recognised by the host, and living bone is laid down directly onto it with no intervening fibrous layer, so implant and host become continuous. This is osseointegration— a true bond, not a mechanical grip.

The distinction was formalised by Hench and Wilson, who divided endosseous implants into bonding and non-bonding classes and showed that surface-active calcium phosphates and bioactive glasses bond to bone through a hydroxyapatite-like surface layer, whereas inert metals are merely encapsulated [1984]. That single idea explains why coating a metallic prosthesis is worthwhile: the coating converts a bioinert, fibrous-capsule interface into a bioactive, bone-bonding one without sacrificing the metal’s mechanics. It also explains why the bulk biocompatibility of titanium — which is excellent — is not the same as having a bone-bonding surface. The widget below contrasts the two interface biologies directly.

There is one caveat to carry through the rest of this module. The bone-bonding of a bioactive surface is conditional: it depends on a dry, healthy, well-aerated host bed. The same bioactive ceramic that integrates beautifully in a quiet ear behaves far less kindly in a wet, infected, atelectatic one — the reactions during chronic middle-ear infection are considerably more severe than in a healthy ear. A coating shifts the odds in the surgeon’s favour; it does not abolish the need for a good environment.

TFrom monolithic ceramics to coatings on metal

The composite idea did not arrive fully formed; it was forced on the field by the failures of the all-ceramic prostheses that came first. In the early 1980s the bioactive glass-ceramic Ceravital was introduced as an ossicular and canal-wall material. Its bioactive surface integrated so well that, remarkably, it could be set against the drum and behave like a homologous ossicle withoutan obligatory cartilage cap — the first hint of what a bioactive interface could buy you [1985]. Early clinical series were encouraging: in a cohort of 37 ears reconstructed with bioactive glass-ceramic, hearing improved in 35 (roughly 95%), confirming that the bioactive interface integrated and conducted well in real patients [1988].

So why are monolithic bioactive ceramics no longer the standard? Because everything that made them biologically excellent also made them mechanically unforgiving. A material that resembles bone mineral shares bone’s brittleness: it is hard and stiff but has almost no ductility, so it does not bend or yield under load — it fractures. Solid bioactive ceramics could not be trimmed with scissors, crimped onto the stapes, or levered to adjust their angle; each manoeuvre shattered or chipped them, and they shaped only by slow diamond-burr abrasion. Ceravital in particular was prone to fragmentation and resorption over time. Goldenberg documented exactly this handling problem with solid hydroxyapatite and, in response, developed the hybridprosthesis — a hydroxyapatite head on a Plasti-Pore shaft — which kept the low extrusion of the ceramic while restoring surgical maneuverability [1992].

That hybrid was the conceptual bridge to the modern composite. Once you accept that the bioactive material need only sit at the interface, the substrate is free to be whatever handles best — and titanium, with its rigidity, low mass, non-ferromagnetism and trimmable open or fenestrated heads, became the obvious choice. The contemporary hydroxyapatite-capped titanium prosthesisis the direct descendant of Goldenberg’s hybrid: bioactive surface where the tissue is, tough workable metal everywhere else.

TAnatomy of a composite prosthesis

It helps to read a composite prosthesis as a stack of zones, each chosen for one property. At the lateral (drum) endsits the bioactive head — a hydroxyapatite cap or a bioactive-coated plate — whose job is to present a bone-bonding, drum-tolerant surface and resist extrusion. In the middle is the metallic shaft, usually titanium, supplying stiffness and low mass and providing the length that the surgeon trims by abrasion or cutting to match the measured drum-to-stapes distance. At the medial end the geometry diverges: a partial prosthesis (PORP) carries a cup or bell that seats on the intact stapes head, while a total prosthesis (TORP) carries a footplate shoe that rests on the stapes footplate when the superstructure is gone.

Two features of this anatomy matter clinically. First, the metallic shaft is what makes the prosthesis visualisable and adjustable: titanium can be milled into open heads that let the surgeon watch the shaft seat on the stapes, something an opaque solid ceramic never allowed. Second, the bioactive head is thin and localised— it adds the interface chemistry without burdening the lightweight body with mass or reintroducing wholesale brittleness, so a small chip at the head does not snap the prosthesis the way a fracture through a monolithic ceramic would. The composite, in short, is engineered so that the brittle component is small and the load-bearing component is tough.

CDoes the coating change the numbers?

The natural clinician’s question is whether all of this materials science actually shows up in outcomes. Two outcome domains are relevant: hearing and extrusion, and they answer differently.

On hearing, the coating buys little or nothing. In the best head-to-head comparison of 168 ears reconstructed with hydroxyapatite versus titanium PORPs and TORPs, both materials gave good functional results with no statistically significant difference in hearing, with only non-significant trends favouring hydroxyapatite in total reconstructions and titanium in partial ones [2007]. A bioactive surface does not transmit sound better than a metallic one; the audiogram is set by coupling and the middle-ear environment, not by surface chemistry. On extrusion and stability, the picture is more favourable to a friendly interface. Bare titanium is not extrusion-proof: a pooled review of eighty titanium PORP and TORP series found an average extrusion or dislocation rate of 5.2%(range 0–35%), which is exactly the problem a bioactive, bone-bonding head — or, more reliably, a cartilage cap — is meant to reduce [2023]. The chart below places these figures side by side.

The practical synthesis is this. A coated or composite design is a sensible default because it costs nothing in hearing and may help at the interface, but the largest, most reliable lever on extrusion remains a thin cartilage capbetween any rigid head and the drum — even for a bioactive ceramic, one direct comparison showed extrusion falling from 13.2% without cartilage to 1.9% with it, at no acoustic cost [2002]. Coatings and cartilage are not rivals; in a marginal ear you use both.

CChoosing and seating a coated prosthesis

Pulling the threads together gives a clear logic. Reach for a hydroxyapatite-capped titaniumor composite prosthesis when you want the trimmability, visualisation and low mass of metal together with a drum-friendlier head — which is to say, in most routine reconstructions. It handles like titanium: trim the shaft to the measured length, seat the medial end on stapes head or footplate, and confirm the lateral end sits flush under the drum. The bioactive head earns its keep most in the favourable ear— dry, well-aerated, healthy mucosa — where its surface can actually bond.

Three cautions keep the decision honest. First, do not over-claim the coating: it improves the interface, but bone-bonding is conditional on a good host bed, and the coating will not rescue a wet, infected or severely atelectatic ear. Second, still cap the interface with cartilagewhenever the ear is atelectatic, revision, or otherwise marginal — the cartilage cap is a larger and more dependable extrusion lever than the coating, and the two combine well [2002]. Third, and most important, keep the material decision in proportion. Comparative data show hearing is much the same across materials [2007], and prognostic staging confirms that the middle-ear environmentand the quality of coupling — not the surface on the head — dominate the long-term result [2001]. A bioactive coating is a refinement at the margins of a decision whose centre lies in the ear, not in the catalogue.